Global transcriptomic profiling via RNA-seq showcasedsignificant downregulation of IRF4 downstream targets38 in two MM cell lines treated withAU-15330 (Figures 4I, 4J, and S5L). This evidence concerns the gene IRF4 and Miyoshi myopathy.